Institutionalizing health technology assessment for priority setting and health policy in Latin America: from regional endeavors to national experiences

Published on Jan 2, 2015in Expert Review of Pharmacoeconomics & Outcomes Research1.828
· DOI :10.1586/14737167.2014.963560
Federico Augustovski25
Estimated H-index: 25
(UBA: University of Buenos Aires),
Andrea Alcaraz6
Estimated H-index: 6
+ 2 AuthorsAndres Pichon-Riviere14
Estimated H-index: 14
(UBA: University of Buenos Aires)
In this paper, we provide a short summary of recent trends and key issues regarding the current status of health technology assessment (HTA) in Latin America. Initially, we describe worldwide and region-wide initiatives that foster the institutionalization of HTA for decision making and health policy in our region. Then, we describe some countries in the region that are worth mentioning for their application of HTA at a national level. The target audiences are those researchers and decision makers interested in following HTA in our region.
  • References (6)
  • Citations (10)
📖 Papers frequently viewed together
2 Citations
11 Citations
28 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Julia ChamovaH-Index: 1
#2Julie Lange (National Board of Health)H-Index: 1
In 2004, health technology assessment (HTA) was recognised as a ‘political priority’ by the EC and Council of Ministers, which led to a call to establish an effective and sustainable European network for HTA (EUnetHTA). The result was the establishment of the EUnetHTA Project in 2006. Since then, the work of this network for cross-border HTA cooperation within Europe has continued through various phases. The most innovative deliverable is the HTA Core Model® - a methodological framework that fac...
30 CitationsSource
2 CitationsSource
OBJETIVO: Identificar y evaluar estudios que analizaron las caracteristicas de los litigios por derecho a la salud en Brasil, Colombia y Costa Rica. METODOS: Se evaluaron estudios que analizaron las caracteristicas de los litigios por derecho a la salud identificados mediante una busqueda en PubMed, LILACS, Biblioteca Cochrane, Scirus (Abril, 2012). Dos revisores evaluaron los estudios. Las variables recabadas fueron, entre otras: causales de litigio, proporcion de demandas por beneficios cubier...
22 CitationsSource
#1Leonardo Cubillos-Turriago (World Bank Institute)H-Index: 2
#2Maria-Luisa Escobar (World Bank Institute)H-Index: 2
Last. Roberto Iunes (World Bank Institute)H-Index: 2
view all 4 authors...
Purpose – Over the last five years many middle‐income Latin American countries have seen a steep increase in the number of cases litigating access to curative services. The purpose of this paper is to explore this complex phenomenon and outline some of its roots and impacts.Design/methodology/approach – The authors use an interdisciplinary approach based on a literature review and workshops convened to discuss the issue.Findings – A range of reasons can explain this increased legal activity. The...
13 CitationsSource
#2Monika WagnerH-Index: 18
Last. Donna RindressH-Index: 9
view all 6 authors...
Background Healthcare decisionmaking is a complex process relying on disparate types of evidence and value judgments. Our objectives for this study were to develop a practical framework to facilitate decisionmaking in terms of supporting the deliberative process, providing access to evidence, and enhancing the communication of decisions.
108 CitationsSource
Cited By10
#1J.T. Insua (Austral University)H-Index: 2
espanolPrinciplism, personalist bioethics and principles of action in medicine and health servicesPrincipialismo, bioetica personalista e principios de acao em medicina e servicos de saudeDado que hay una brecha y diferencias entre conceptos bioeticos y otros principios de accion provenientes de la practica de la medicina moderna, su comparacion es razonable. La medicina moderna ha generado principios de accion basados en la evidencia y principios de calidad en medicina, y la argumentacion bioet...
#1Florian Dams (University of Bern)
#2Javier Leonardo González Rodríguez (Del Rosario University)H-Index: 1
Last. Mickaël Hiligsmann (PHRI: Public Health Research Institute)H-Index: 28
view all 5 authors...
AbstractObjectives: Several studies, mostly from developed countries, have identified barriers and facilitators with regard to the uptake of health technology assessment (HTA). This study elicited, using best-worst scaling (BWS), what HTA experts in Colombia consider to be the most important barriers and facilitators in the use of HTA, and makes a comparison to results from the Netherlands.Methods: Two object case surveys (one for barriers, one for facilitators) were conducted among 18 experts (...
Objectives: The aim of this study was to identify good practice principles for health technology assessment (HTA) that are the most relevant and of highest priority for application in Latin America and to identify potential barriers to their implementation in the region. Methods: HTA good practice principles proposed at the international level were identified and then explored during a deliberative process in a forum of assessors, funders, and product manufacturers. Results: Forty-two representa...
3 CitationsSource
2 CitationsSource
OBJECTIVES: The aim of this study was to describe the historical development of the HTAsiaLink network, draw lessons for other similar initiatives globally, and to analyze key determinants of its success and challenges for its future development. METHODS: This study is based on the collective and direct experiences of the founding members of the HTAsiaLink Network. Data were collected from presentations they made at various international forums and additional information was reviewed. Data analy...
1 CitationsSource
#1Diego Rosselli (Pontifical Xavierian University)H-Index: 12
#2C Quirland-Lazo (University of Chile)H-Index: 1
Last. Zoltán Kaló (ELTE: Eötvös Loránd University)H-Index: 18
view all 10 authors...
Abstract Objectives To provide an overview about the current status of health technology assessment (HTA) implementation in Latin American countries and to identify long-term objectives considering regional commonalities. Methods We conducted a survey among participants of the 5th Latin American Future Trends Conference in October 2015. Thirty-seven respondents from eight Latin American countries provided insights about the current and preferred future status of HTA implementation related to hum...
4 CitationsSource
#1Rossana Ruiz (Harvard University)H-Index: 7
Last. Paul E. Goss (Harvard University)H-Index: 72
view all 8 authors...
Lack of access to high-cost medications is a complex issue at the intersection of economics, medicine, politics, and ethics, and it poses a significant threat to global health care. The problem is even more significant in low- and middle-income countries, such as those in Latin America, where governments and individuals struggle to pay for products that are priced at several times the level of their per capita gross domestic product. In this review, we examine the determinants for increasing dru...
7 CitationsSource
#1Eleanor M. Perfetto (UMB: University of Maryland, Baltimore)H-Index: 9
#2Em Oehrlein (UMB: University of Maryland, Baltimore)H-Index: 3
Last. Eric GaschoH-Index: 1
view all 5 authors...
Abstract Background Professional societies and other organizations have recently taken a visible role trying to define treatment value via value frameworks and assessments, providing payer or provider recommendations, and potentially impacting patient access. Patient perspectives routinely differ from those of other stakeholders. Yet, it is not always apparent that patients were engaged in value framework development or assessment. Objectives To describe the development and content of the Nation...
15 CitationsSource
Universal healthcare coverage (UHC) is now firmly on the global health agenda. In December 2012, the UN Assembly voted for UHC, with wide-ranging support including from the US and UK governments, and calling on countries to provide “access to key promotive, preventive, curative and rehabilitative health interventions for all at an affordable cost” [1]. The Washington Post ran the news with the headline ‘Obamacare Everywhere’ [2], drawing parallels with the US debate on expanding insurance to cov...
1 CitationsSource
#1Jack Dowie (Lond: University of London)H-Index: 16
#2Mette Kjer KaltoftH-Index: 3
Last. Glenn Salkeld (USYD: University of Sydney)H-Index: 35
view all 4 authors...
Concern with the threshold applied in cost-effectiveness analyses by bodies such as NICE distracts attention from their biased use of the principle. The bias results from the prior requirement that an intervention be effective (usually 'clinically effective') before its cost-effectiveness is considered. The underlying justification for the use of cost-effectiveness as a criterion, whatever the threshold adopted, is that decisions in a resource-constrained system have opportunity costs. Their exi...